DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Iacoviello L, Agnoli C, De Curtis A. et al.
Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study.
BMJ Open 2013;
3 (11) e003725
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.